HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine: a cross-sectional survey.
BACKGROUND
Ukraine has experienced an increase in injection drug use since the 1990s. An increase in HIV and hepatitis C virus infections has followed, but not measures of prevalence and risk factors. The purposes of this study are to estimate the prevalence of HIV, HCV, and co-infection among injection drug users (IDUs) in central Ukraine and to describe risk factors for HIV and HCV.


METHODS
A sample of 315 IDUs was recruited using snowball sampling for a structured risk interview and HIV/HCV testing (81.9% male, 42% single, average age 28.9 years [range = 18 to 55]).


RESULTS
HIV and HCV antibodies were detected in 14.0% and 73.0%, respectively, and 12.1% were seropositive for both infections. The most commonly used drug was hanka, home-made from poppy straw and often mixed with other substances including dimedrol, diazepines, and hypnotics. The average period of injecting was 8.5 years; 62.5% reported past-year sharing needles or injection equipment, and 8.0% shared with a known HIV-positive person. More than half (51.1%) reported multiple sexual partners, 12.9% buying or selling sex, and 10.5% exchanging sex and drugs in the past year. Those who shared with HIV positive partners were 3.4 times more likely to be HIV positive than those who did not. Those who front- or back-loaded were 4 times more likely to be HCV positive than those who did not.


CONCLUSIONS
Harm reduction, addiction treatment and HIV prevention programs should address risk factors to stop further spread of both HIV and HCV among IDUs and to the general population in central Ukraine.
Dumchev
Kostyantyn V
KV
Division of Preventive Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA. k.dumchev@gmail.com
Soldyshev
Ruslan
R
Qian
Han-Zhu
HZ
Zezyulin
Olexandr O
OO
Chandler
Susan D
SD
Slobodyanyuk
Pavel
P
Moroz
Larisa
L
Schumacher
Joseph E
JE
Hepatology. 2002 Jan;35(1):182-9
11786975
AIDS. 2006 Nov 14;20(17):2217-23
17086062
AIDS. 2004 Jan 2;18(1):1-12
15090824
J Hepatol. 2006;44(1 Suppl):S6-9
16352363
Zh Mikrobiol Epidemiol Immunobiol. 2000 Sep-Oct;(5):35-9
11220962
Bull World Health Organ. 1999;77(10):789-800
10593026
Am J Epidemiol. 2002 Apr 1;155(7):645-53
11914192
MMWR Recomm Rep. 2001 Nov 9;50(RR-19):1-57; quiz CE1-19a1-CE6-19a1
11718472
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8
16769443
Subst Use Misuse. 2003 Dec;38(14):2049-63
14677781
World J Gastroenterol. 2004 Jun 1;10(11):1589-93
15162531
N Engl J Med. 2002 Sep 26;347(13):975-82
12324553
J Nerv Ment Dis. 1987 Sep;175(9):566-74
3655783
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):154-62
12394793
Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S49-55
16769446
Harm Reduct J. 2005 Sep 15;2(1):16
16164758
Am J Trop Med Hyg. 2006 Jun;74(6):1111-6
16760529
Addiction. 2006 Feb;101(2):252-66
16445554
Qual Life Res. 2000 Feb;9(1):55-63
10981206
Eur Addict Res. 2002 Nov;8(4):184-9
12457059
Sex Transm Infect. 2008 Aug;84 Suppl 1:i37-i41
18647864